Learning Objectives:

1.  Raise awareness of hereditary amyloidosis (ATTRv) as a possible diagnosis of idiopathic neuropathy.

2.  Discuss what to look for to screen patients at higher risk for ATTRv.

3.  Recognize the various advancements in disease modifying therapy.

Session date: 
06/18/2024 - 8:00am to 9:00am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Richard Wlodarski, MD